Government ContextGovernment Context
TopicsAgenciesOrganizationsDocumentsPricingLog inCreate account
TopicsAgenciesOrganizationsDocumentsPricing
LoginCreate account
DetailsRelated

Amendment to data presented in EXHIBIT 13 (7.9.2026)

Supporting & Related MaterialFDA-2026-P-6249-0374
Document

Details

The document's own metadata, straight from the source system.

Title
Amendment to data presented in EXHIBIT 13 (7.9.2026)
Posted
Jul 14, 2026
Agency
Food and Drug Administration (FDA)
Topics
  • Animal Health & Welfare
  • Pharmaceutical Policy
View on regulations.gov ↗
Related

Related documents

Other documents filed with this rulemaking.

View related documents
Supporting & Related Material
javma-javma.26.03.0170
No comment periodJul 14, 2026
Supporting & Related Material
Librela All Cases (updated based on Q1 2026 data pub by FDA JSON)
No comment periodJul 14, 2026
Other
Citizen Petition from Pharmaceutical Safety Oversight Council
No comment period · 6Jun 3, 2026
Supporting & Related Material
Exhibit 09(c) - Librela (bedinvetmab injection) Client Information Sheet
No comment periodJun 3, 2026
Supporting & Related Material
Exhibit 09(b) - Librela (bedinvetmab injection) US Prescribing Information Revised (January2025)
No comment periodJun 3, 2026

On this page

DetailsRelated
Government ContextGovernment Context

Track federal rulemaking documents, topics, and agencies — built on primary sources across the federal government.

ExploreDocumentsTopicsAgenciesOrganizations
CompanyAboutData sourcesPricing
LegalPrivacyTerms
© 2026 Government Context. Built on primary government sources.Not affiliated with any U.S. government agency.